14
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Clinical Significance of Relative Probe-Tone Levels on Distortion Product Otoacoustic Emissions

, , &
Pages 223-229 | Received 25 Jun 1992, Accepted 24 Aug 1992, Published online: 12 Oct 2009
 

Abstract

The effect of systematic variations in the relative levels (L1, L2) of two primary tones (f1, f2) on the amplitude of the distortion product otoacoustic emission (DPOAE) at 2f1-f2 and f1 < f2 was investigated in 14 ears from 7 normally hearing human subjects. The primary tones (f2:f1 = 1.23) were geometrically centred at the standard clinical frequencies of 0.5,1,1.5,2,3,4,6 and 8 kHz. The quantity L1 L2 was varied systematically from – 10 dB through + 10 dB with L2 held constant at 75 dB SPL for negative values, L1 held constant at 75 dB SPL for positive values, and L1 = L2 = 75 dB SPL at 0 dB relative difference. The maximum amplitudes of the distortion products were generated when L1 = L2 at all geometric centre frequencies except 8 kHz. The reduction of the DPOAE with reduction of L1 was linear at a rate that gradually increased as a function of geometric mean frequency. To a lesser extent, the reduction of the DPOAE with reduction of L2 also was linear but at a rate that systematically decreased as a function of geometric mean frequency. The results suggest, that to maximize the level of the distortion product for clinical purposes, the relative levels of the primary tones should be equal to each other, at least when overall stimulus levels are around 75 dB SPL and f2:f1 = 1.23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.